Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrganoClick AB's gross profit for the
three
months ended in Mar. 2026 was €0.77 Mil. OrganoClick AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was €1.31 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. OrganoClick AB's gross profit for the
three
months ended in Mar. 2026 was €0.77 Mil. OrganoClick AB's Revenue for the
three
months ended in Mar. 2026 was €2.54 Mil. Therefore, OrganoClick AB's Gross Margin % for the quarter that ended in Mar. 2026 was 30.46%.
OrganoClick AB had a gross margin of 30.46% for the quarter that ended in Mar. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of OrganoClick AB was 35.20%. The lowest was 11.24%. And the median was 20.44%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
OrganoClick AB had a gross margin of 30.46% for the quarter that ended in Mar. 2026 => Competition eroding margins
OrganoClick AB Gross Profit Related Terms
OrganoClick AB Gross Profit Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, OrganoClick AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB Gross Profit vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's Gross Profit distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.31 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
OrganoClick AB (FRA:0CF) has a Gross Profit of €1.31 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on OrganoClick AB and its competitors.
Is OrganoClick AB's Gross Profit too high?
OrganoClick AB's current Gross Profit is €1.31 Mil. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Gross Profit compare to LIN and SHW?
OrganoClick AB's Gross Profit of €1.31 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Chemicals company?
A good Gross Profit depends on the Chemicals industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on OrganoClick AB and its competitors. OrganoClick AB's current Gross Profit is €1.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current Gross Profit of €1.31 Mil. The stock's GF Value™ is €0.13, compared to a current price of €0.03 — trading 79.1% below its estimated fair value. The current Gross Profit is €1.31 Mil. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current Gross Profit is €1.31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (FRA:0CF) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of €0.03 is trading 79.1% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:0CF:
Gross Profit: €1.31 Mil
GF Value™: €0.13 vs. price of €0.03 (79.1% below fair value)
No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for FRA:0CF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0CF has been successfully added to your 
